483
Catalent Massachusetts, LLCFDA 483 - Catalent Massachusetts, LLC - November 30, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Catalent Massachusetts, LLC, a drug product manufacturer in Chelsea, MA, revealed significant deficiencies across four observations. The firm was cited for inadequate equipment requalification, insufficient procedures to prevent objectionable microorganisms, and failure to validate supplier analyses for components. Additionally, cleaning and maintenance procedures for GMP manufacturing areas were found to be deficient.
Open in Dashboard
ID · 34e634e0-938c-4d07-9487-76f1d7f953a4